UBS Group AG

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$64,601	56,668	-26	-0.05%	$1.14	Q4 2025
30 Sep 2025	0%	-0%	$72,001	56,694	-5,306	-8.6%	$1.27	Q3 2025
30 Jun 2025	0%	-0%	$65,720	62,000	-44,021	-42%	$1.06	Q2 2025
31 Mar 2025	0%	-0%	$144,189	106,021	-64,271		$1.36	Q1 2025
31 Dec 2024	0%	+0%	$235,003	170,292	+170,292	NEW	$1.38	Q4 2024
30 Sep 2024		-0%	$0	0	-17,483	-100%	$1.32	Q3 2024
30 Jun 2024	0%	-0%	$37,588	17,483	-2,091	-11%	$2.15	Q2 2024
31 Mar 2024	0%	+0%	$63,616	19,574	+19,574	NEW	$3.25	Q1 2024
31 Dec 2023		-0%	$0	0	-41,046	-100%	$1.32	Q4 2023
30 Sep 2023	0%	-0%	$660,020	41,046	-8,627	-17%	$16.08	Q3 2023
30 Jun 2023	0%	-0%	$422,221	49,673	-2,552	-4.9%	$8.50	Q2 2023
31 Mar 2023	0%	+0%	$515,461	52,225	+770	+1.5%	$9.87	Q1 2023
31 Dec 2022	0%	+0%	$490,366	51,455	+22,348	+77%	$9.53	Q4 2022
30 Sep 2022	0%	-0%	$506,000	29,107	-19,260	-40%	$17.38	Q3 2022
30 Jun 2022	0%	+0%	$375,000	48,367	+47,209	+4077%	$7.75	Q2 2022
31 Mar 2022	0%	+0%	$17,000	1,158	+1,158	NEW	$14.68	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.